Clinical practice. Graves' disease. [N Engl J Med. 2008] - PubMed

loading

[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995]. [Med Clin (Barc). 1998]
[Evolution of diagnostic and therapeutic criteria in Graves' disease in Spain. Comparison of the results of 2 surveys in 1987 and 1995].
Escobar Jiménez F, Luna López V, Fernández Soto ML, Quezada Charneco M, Glinoer D. Med Clin (Barc). 1998 Sep 5; 111(6):205-10.
[Cardiothyrotoxicoses]. [Sem Hop. 1974]
[Cardiothyrotoxicoses].
Lanfranchi J. Sem Hop. 1974 Apr 26; 50(20):1367-70.
Review Hyperthyroidism. Current treatment guidelines. [Drugs. 1998]
Review Hyperthyroidism. Current treatment guidelines.
Gittoes NJ, Franklyn JA. Drugs. 1998 Apr; 55(4):543-53.
A case of severe cholestatic jaundice associated with Graves' disease. [Turk J Gastroenterol. 2008]
A case of severe cholestatic jaundice associated with Graves' disease.
Soysal D, Tatar E, Solmaz S, Kabayeğit O, Tunakan M, Unsal B, Cevik C. Turk J Gastroenterol. 2008 Mar; 19(1):77-9.
Review [Basedow's disease]. [Schweiz Rundsch Med Prax. 1993]
Review [Basedow's disease].
Scheidegger K. Schweiz Rundsch Med Prax. 1993 Aug 10; 82(32):840-4.

A patient with Graves' disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody. [Thyroid Res. 2012]
A patient with Graves' disease showing only psychiatric symptoms and negativity for both TSH receptor autoantibody and thyroid stimulating antibody.
Hamasaki H, Yoshimi T, Yanai H. Thyroid Res. 2012 Dec 3; 5(1):19. Epub 2012 Dec 3.
Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritis. [Case Rep Nephrol Urol. 2012]
Thyroid storm masked by hemodialysis and glucocorticoid therapy in a patient with rheumatoid arthritis.
Sasaki Y, Shimizu Y, Nakata J, Kameda T, Muto M, Ohsawa I, Io H, Hamada C, Horikoshi S, Tomino Y. Case Rep Nephrol Urol. 2012 Jan; 2(1):6-10. Epub 2012 Feb 16.
Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease. [PLoS One. 2012]
Decrease in proportion of CD19+ CD24(hi) CD27+ B cells and impairment of their suppressive function in Graves' disease.
Zha B, Wang L, Liu X, Liu J, Chen Z, Xu J, Sheng L, Li Y, Chu Y. PLoS One. 2012; 7(11):e49835. Epub 2012 Nov 26.

Related Citations
Calculated set of PubMed citations closely related to the selected article(s) retrieved using a word weight algorithm. Related articles are displayed in ranked order from most to least relevant, with the “linked from” citation displayed first.
Compound (MeSH Keyword)
PubChem chemical compound records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Substance (MeSH Keyword)
PubChem chemical substance (submitted) records that are classified under the same Medical Subject Headings (MeSH) controlled vocabulary as the current articles.
Cited in PMC
Full-text articles in the PubMed Central Database that cite the current articles.
Cited in Books
NCBI Bookshelf books that cite the current articles.

Clinical practice. Graves' disease.
Clinical practice. Graves' disease.
N Engl J Med. 2008 Jun 12 ;358(24):2594-605. doi: 10.1056/NEJMcp0801880.

PubMed

Your browsing activity is empty.

Activity recording is turned off.

PubMed